Murata Manufacturing Co., Ltd. (MRAAF)

Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	28,077	28,673	35,273	38,086	42,768	51,151
Market Cap Growth	-28.76%	-18.71%	-7.39%	-10.95%	-16.39%	57.21%
Enterprise Value	24,988	25,242	32,835	35,828	39,637	49,865
Last Close Price	15.37	16.56	18.70	19.60	21.39	26.04
PE Ratio	18.65	18.37	29.50	19.96	16.53	23.87
PS Ratio	2.33	2.46	3.25	3.00	2.87	3.47
PB Ratio	1.61	1.66	2.09	2.11	2.29	2.94
P/TBV Ratio	1.73	1.79	2.24	2.27	2.48	3.12
P/FCF Ratio	15.59	15.96	20.44	58.65	19.17	32.57
P/OCF Ratio	9.35	9.50	10.90	18.33	12.32	15.14
EV/Sales Ratio	2.14	2.17	3.03	2.82	2.66	3.38
EV/EBITDA Ratio	7.94	7.99	11.37	10.36	8.26	12.09
EV/EBIT Ratio	12.59	12.61	19.03	15.96	11.26	17.61
EV/FCF Ratio	13.88	14.05	19.03	55.17	17.77	31.75
Debt / Equity Ratio	0.02	0.02	0.04	0.06	0.06	0.10
Debt / EBITDA Ratio	0.13	0.13	0.24	0.34	0.25	0.40
Debt / FCF Ratio	0.23	0.22	0.41	1.79	0.53	1.05
Asset Turnover	0.58	0.57	0.56	0.59	0.69	0.69
Inventory Turnover	2.03	2.06	1.84	1.95	2.53	2.90
Quick Ratio	3.36	3.33	2.88	2.52	2.89	2.49
Current Ratio	5.84	5.42	4.72	4.64	4.47	3.73
Return on Equity (ROE)	8.48%	9.07%	7.27%	10.86%	15.00%	13.11%
Return on Assets (ROA)	6.19%	6.18%	5.52%	6.57%	10.13%	8.31%
Return on Capital (ROIC)	7.01%	7.07%	6.25%	7.52%	11.95%	9.70%
Return on Capital Employed (ROCE)	11.00%	10.90%	9.60%	11.60%	17.20%	14.60%
Earnings Yield	5.36%	5.45%	3.39%	5.01%	6.05%	4.19%
FCF Yield	6.41%	6.26%	4.89%	1.70%	5.22%	3.07%
Dividend Yield	2.61%	2.30%	1.84%	1.92%	1.67%	1.33%
Payout Ratio	49.01%	43.44%	52.23%	36.27%	24.44%	28.34%
Buyback Yield / Dilution	1.32%	1.07%	0.38%	1.20%	-0.00%	-0.00%
Total Shareholder Return	3.94%	3.37%	2.22%	3.12%	1.67%	1.33%

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.